Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has released its financial results for the fourth quarter and year-ended October 31, 2022. Saviuk telling Proactive the company saw record quarterly revenues of 12.7 million dollars in Q4 2022 which is up 274% year over year. Valeo also saw record annual revenues of 27.7 million for 2022, compared to $13.6 million in 2021, up 105%. Saviuk also shared more details about what has led the company in revenue and what is planned in 2023 to fuel the momentum.
Valeo Pharma 4th Quarter and fiscal 2022 financials showing record revenue
